368 related articles for article (PubMed ID: 17239999)
1. Biological safety concepts of genetically modified live bacterial vaccines.
Frey J
Vaccine; 2007 Jul; 25(30):5598-605. PubMed ID: 17239999
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
Viret JF; Dietrich G; Favre D
Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
[TBL] [Abstract][Full Text] [Related]
4. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
Spreng S; Viret JF
Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
[TBL] [Abstract][Full Text] [Related]
5. Live bacterial vaccines--a review and identification of potential hazards.
Detmer A; Glenting J
Microb Cell Fact; 2006 Jun; 5():23. PubMed ID: 16796731
[TBL] [Abstract][Full Text] [Related]
6. Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation.
Favre D; Viret JF
Vaccine; 2006 May; 24(18):3856-64. PubMed ID: 16115705
[TBL] [Abstract][Full Text] [Related]
7. Salmonella: immune responses and vaccines.
Mastroeni P; Chabalgoity JA; Dunstan SJ; Maskell DJ; Dougan G
Vet J; 2001 Mar; 161(2):132-64. PubMed ID: 11243685
[TBL] [Abstract][Full Text] [Related]
8. Development of improved attenuated and nucleic acid vaccines for heartwater.
Collins NE; Pretorius A; van Kleef M; Brayton KA; Allsopp MT; Zweygarth E; Allsopp BA
Dev Biol (Basel); 2003; 114():121-36. PubMed ID: 14677683
[TBL] [Abstract][Full Text] [Related]
9. [Fundamental safety requirements in the use of live vaccine in food animals].
Selbitz HJ
Berl Munch Tierarztl Wochenschr; 2001; 114(11-12):428-32. PubMed ID: 11766270
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
12. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
Haslberger AG
J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
[TBL] [Abstract][Full Text] [Related]
13. Envelope exchange for the generation of live-attenuated arenavirus vaccines.
Bergthaler A; Gerber NU; Merkler D; Horvath E; de la Torre JC; Pinschewer DD
PLoS Pathog; 2006 Jun; 2(6):e51. PubMed ID: 16751848
[TBL] [Abstract][Full Text] [Related]
14. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus vaccine studies: from past to present].
Us D
Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
[TBL] [Abstract][Full Text] [Related]
17. Developing live Shigella vaccines using lambda Red recombineering.
Ranallo RT; Barnoy S; Thakkar S; Urick T; Venkatesan MM
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):462-9. PubMed ID: 16872384
[TBL] [Abstract][Full Text] [Related]
18. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
19. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
20. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
Walker RI
Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
